Keyword: Epogen

AstraZeneca

5. Roxadustat

FibroGen's AstraZeneca-partnered anemia drug roxadustat was first approved in China. Leerink analyst Geoffrey Porges has projected sales of about $1 billion in China alone by 2025.
amgen

11. Amgen

After two straight years at number 12 on FiercePharma’s list of the top pharma companies by revenues, Amgen moved up one spot with 2018 sales of $23.75 billion.